REGULATORY

• China Formally Arrests Astellas Employee, Japan Urges Immediate Release
  October 20, 2023

• Japan to Buy 10 Million More Doses of Pfizer/Moderna COVID Jabs
  October 19, 2023

• Health Minister Requests 8 Makers to Bolster Supplies of Antitussive, Expectorant Agents
  October 19, 2023

• Leqembi’s Initial Pricing Won’t Factor in Benefits in Long-Term Care
  October 19, 2023

• Chuikyo at Odds over Handling of Startups in PMP, Timing of Deferred Price Cuts
  October 19, 2023

• Medipharma Might Face Administrative Penalty over Trial Data Tampering
  October 18, 2023

• Average Price Gap for 2024 Revision Looks to Be Lower than 7.0%: Wholesalers
  October 18, 2023

• AMED Group to Draft Master Protocols Guidelines by March-End, Frets Further Drug Lag/Loss
  October 17, 2023

• MHLW Sets Up Hotline for Production Site Change for Supply-Crippled Drugs
  October 17, 2023

• Health Minister Laments Drug Lag/Loss, Stresses Need for Govt-Driven Innovation Ecosystem
  October 16, 2023

• MHLW Regulatory Panel OKs New Procedures for Post-Approval Manufacturing Changes
  October 16, 2023

• Japan’s New Economic Package to Include Dementia Measures: PM
  October 16, 2023

• Xarelto’s Label Expansion Up for Japan Panel Review on Oct. 27
  October 16, 2023

• MHLW to Swiftly Deliberate Additional Purchase of COVID Jabs: Minister
  October 16, 2023

• Label Revisions Ordered for G-CSF Agents, Yervoy and More
  October 13, 2023

• MHLW Preparatory Council Boots Up for Japan-Version of CDC
  October 13, 2023

• MHLW Panel Proposes Assessing Generic Makers’ Efforts toward Stable Supplies, Reflecting Results in Pricing
  October 12, 2023

• Drug Innovation Measures Likely to Be Embraced in Govt Economic Package
  October 12, 2023

• Vyvgart, Dysval Braced for Price Cuts after CEA, No Change for Ondexxya
  October 12, 2023

• MHLW Pondering Every Possible Avenue to Supply Cough Drugs: Minister
  October 11, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 70
• 71
• 72
• 73
• 74
• 75
• 76
• 77
• 78
• …
• Next ›
• 最終 »